Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hanwha Aerospace (012450) – (Correction) Paid-in Capital Increase Decision / 2025-04-08

Posted on April 8, 2025August 10, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Aerospace (012450) – (Correction) Paid-in Capital Increase Decision / 2025-04-08

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Hanwha Aerospace has disclosed that it is revising its paid-in capital increase plan to reduce the shareholder rights offering portion from KRW 3.6T to KRW 2.3T, while reviewing various options, including a potential third-party allotment without discount for affiliates such as Hanwha Energy to cover the remaining KRW 1.3T.

📊 [Key Disclosure Contents & Major Financial Figures]

1. Correction Overview and Reason

  • Target Document: Major Report (Paid-in Capital Increase Decision) (Originally filed on March 20, 2025)
  • Reason for Revision: Adjustments to the terms and details of the paid-in capital increase

2. Key Revised Terms & Financial Figures

  • Type and Number of New Shares: 4,267,200 Common Shares
  • Par Value per Share: KRW 5,000
  • Total Issued Shares Before Capital Increase: 45,581,161 Common Shares
  • Use of Proceeds (Totaling KRW 2.3000002008T):
    • Facility Investment: KRW 700.02B
    • Acquisition of Securities in Other Corporations: KRW 1.6T
  • Method of Capital Increase: Rights offering to existing shareholders followed by a public offering of unsubscribed shares
  • Expected Issue Price: KRW 539,000 per common share (15% discount rate applied)
  • Record Date for Share Allocation: April 24, 2025
  • New Shares Allocated per Existing Share: 0.0750828939 shares per common share
  • Employee Stock Ownership Association Priority Allocation: 20.0% (853,440 shares)
  • Subscription and Payment Schedule:
    • Subscription Period (Employees & Existing Shareholders): June 04, 2025 – June 05, 2025
    • General Public Offering Subscription Period: June 10, 2025 – June 11, 2025
    • Payment Date: June 13, 2025
    • Expected Listing Date of New Shares: June 25, 2025
  • Lead Underwriters: NH Investment & Securities, Korea Investment & Securities

3. Other Crucial Matters

  • Adjusted the shareholder rights offering portion down by KRW 1.3T (from KRW 3.6T to KRW 2.3T) to alleviate the subscription burden on existing shareholders and improve transaction execution.
  • The company is currently reviewing various plans, including a third-party allotment of approximately KRW 1.3T without discount involving affiliates like Hanwha Energy. Specific details are expected to be finalized and disclosed within April 2025.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Confirmation of Final Decision on Third-Party Allotment Plan

This disclosure indicates a reduction in the shareholder rights offering amount alongside the ongoing review of a potential third-party allotment involving affiliates for the remaining KRW 1.3T. Monitoring subsequent disclosures to verify whether this proposed third-party participation plan is officially confirmed is important for understanding the finalized capital-raising arrangement. Relevant updates can be verified through future regulatory filings concerning capital increases or under the ‘Changes in Capital Stock’ section of upcoming periodic reports.

📢 Disclaimer and Source Notice

Source: This content was newly generated and structured based on official data filed with the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.

Disclosures, Defense

Post navigation

Previous Post: [Disclosure] ISU PETASYS(007660) – Issue Price Determination for Rights Offering / 2025-04-07
Next Post: [Disclosure] Hanwha Aerospace (012450) – (Correction) Paid-in Capital Increase Decision / 2025-04-08

Related Posts

[Disclosure] Celltrion (068270) – New Facility Investment / 2026-03-24 Disclosures
[Disclosure] Samsung Electro-Mechanics (009150) – Investor Relations (IR) Schedule Announcement / 2026-07-09 Disclosures
[Disclosure] ALTEOGEN (196170) – Submission of Audit Report / 2024-03-18 Disclosures
[Disclosure] Celltrion (068270) – CT-P55 (Cosentyx Biosimilar) Europe Marketing Authorization Application / 2026-07-24 Disclosures
[Disclosure] PSK Holdings (031980) – Investor Relations (IR) Host / 2025-11-20 Semiconductors
[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in Europe (Part 1 & 2) / 2024-12-13 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Systems (272210) – Decision on Acquisition of Shares and Investment Certificates of Other Corporations (Correction) / 2026-08-10August 10, 2026
  • [Disclosure] Hanwha Aerospace (012450) – Decision on Convening General Meeting of Shareholders / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Aerospace (012450) – Setting of Record Date for Shareholder Register Closure / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme